Atria Investments LLC Centessa Pharmaceuticals PLC Transaction History
Atria Investments LLC
- $7.49 Billion
- Q4 2024
A detailed history of Atria Investments LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Atria Investments LLC holds 13,774 shares of CNTA stock, worth $233,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,774
Previous 17,134
19.61%
Holding current value
$233,607
Previous $273,000
15.75%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$339 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$169 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$164 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$108 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$98.5 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...